These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11975087)

  • 1. [Intravenous immunoglobulins in multiple sclerosis. Studies and mechanisms of action--an update].
    Stangel M; Hartung HP
    Nervenarzt; 2002 Feb; 73(2):119-24. PubMed ID: 11975087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
    Trebst C; Stangel M
    Curr Pharm Des; 2006; 12(2):241-9. PubMed ID: 16454740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
    Stangel M; Bernard D
    J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune promotion of central nervous system remyelination.
    Rodriguez M; Miller DJ
    Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
    Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous immunoglobulin treatment of multiple sclerosis.
    Durelli L; Isoardo G
    Neurol Sci; 2002 Apr; 23 Suppl 1():S39-48. PubMed ID: 12032586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of endogenous remyelination in multiple sclerosis.
    Lucchinetti CF; Noseworthy JH; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):71-5. PubMed ID: 9291156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
    Sørensen PS
    Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG?
    Warrington AE; Van Keulen V; Pease LR; Rodriguez M
    Adv Exp Med Biol; 2012; 750():44-55. PubMed ID: 22903665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.
    Noseworthy JH; O'Brien PC; van Engelen BG; Rodriguez M
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):11-4. PubMed ID: 7964842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.
    Mecha M; Feliú A; Carrillo-Salinas FJ; Mestre L; Guaza C
    Exp Neurol; 2013 Dec; 250():348-52. PubMed ID: 24148569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update].
    Stangel M; Gold R
    Nervenarzt; 2005 Oct; 76(10):1267, 1269-70, 1272. PubMed ID: 15902390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intravenous immunoglobulin in the treatment of multiple sclerosis.
    Sorensen PS
    J Neurol Sci; 2003 Feb; 206(2):123-30. PubMed ID: 12559498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease.
    Rodriguez M
    J Neuroimmunol; 1992 Oct; 40(2-3):255-63. PubMed ID: 1430155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.
    van Engelen BG; Miller DJ; Pavelko KD; Hommes OR; Rodriguez M
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):65-8. PubMed ID: 7964859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.
    Wiendl H; Hohlfeld R
    BioDrugs; 2002; 16(3):183-200. PubMed ID: 12102646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis.
    Drescher KM; Rivera-Quinones C; Lucchinetti CF; Rodriguez M
    J Neuroimmunol; 1998 Aug; 88(1-2):111-9. PubMed ID: 9688332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.